Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy.

The waterfall plot similarly showed a strong trend between PDC AUC values and the clinical tumor response to EGFR- or ALK-TKIs ( Figure 3 B).

also in 5,725 other papers